Immunotherapy is an increasingly popular method in the treatment of cancer

immunotherapy is becoming increasingly popular in the treatment of cancer

5 out of 1 people in the world will be diagnosed with cancer in their lifetime. 8 out of 1 men and 11 out of 1 women die of cancer. According to the estimate report prepared by the American Cancer Society; A total of 2022 million new cancer cases are expected in 1.9.

5 out of 1 people in the world will be diagnosed with cancer in their lifetime. 8 out of 1 men and 11 out of 1 women die of cancer. According to the estimate report prepared by the American Cancer Society; A total of 2022 million new cancer cases are expected in 1.9. Professor Necdet Üskent, Medical Oncology Specialist and Coordinator of Oncological Sciences at Anadolu Medical Center, said: “The most important difference between immunotherapies and chemotherapy is that it does not contain chemicals and directs natural warrior cells from the body to the tumor. Naturally, the side effects are much less compared to chemotherapy,” he said. Professor Necdet Üskent gave important information on the subject on the occasion of Cancer Week from April 1 to 7…

Professor Necdet Üskent, Medical Oncology Specialist and Coordinator of Oncological Sciences at Anadolu Health Center, said: “The most important difference between immunotherapies and chemotherapy is that it does not contain chemicals and directs the warrior cells of the body towards the tumour. In other words, it targets the immune system, not the tumor like chemotherapy, and allows immune system cells to fight the tumor. Naturally, the side effects are much less compared to chemotherapy,” he said.

Hair loss seen in chemotherapy does not occur in immunotherapy treatment.

Emphasizing that hair loss, which is seen in conventional chemotherapy drugs, is not seen in immunotherapy drugs known as checkpoint inhibitors, the Oncology Specialist and Coordinator of Oncology Sciences, Professor Necdet Üskent, said: “Furthermore, the warrior cells (immune cells) stimulated by immunotherapy can attack normal cells along with cancer cells. In order to prevent this, studies are also carried out to mark cancer cells. This happens with vaccines such as CAR-T cells. It can be said that side effects occur mostly in the first 3 months from the week of treatment. However, side effects may occur up to 1 year after the end of treatment. Immune pneumonia, decrease in thyroid and pituitary hormones, intestinal inflammation which we call colitis are some of these side effects. However, they are rarely seen at a rate of 2-5% and they are easy to control. Importantly, side effects that are noticed and intervened early are often mild and temporary.

Immunotherapy can be used alone or in combination with chemotherapy.

Recalling that many drugs can be mentioned in the immunotherapy used today, Pr Dr Necdet Üskent, “The most frequently used of them is the ‘Checkpoint Inhibitors’ (Checkpoint Inhibitor). Today these drugs, which dramatically improve many cancers and are increasingly used, work by blocking ‘checkpoint proteins’ that prevent the immune system from attacking the cancer cell. Like chemotherapy, it is administered by intravenous serum and does not require any special preparation before application. While it was only used in the generalized stage when it was first developed, it is now used in combination with chemotherapy in early-stage cancers. In this way, longer term recovery and control of the disease can be achieved.

Cancer treatment by immunotherapy will become widespread

Professor Necdet Üskent, specialist in oncology and coordinator of oncological sciences, said: “There will always be interference with the tumor DNA and the mitosis of the cancer cell with chemicals. But it is a fact that the use of immunotherapy will become widespread. While still used in late-stage cancers today, it will be used more frequently in years to come in the early stages and as preparation for surgery. Success rates in clinical studies also support these estimates.

Comments are closed.